The substitution, using site-directed mutagenesis, of asparagine by alanine at glycosylation sites, was found to reduce N-glycosylated ICAM-2, displaying a significantly attenuated ability to suppress metastatic properties of NB cells (49). The gene discussed is ICAM2; the disease is neuroblastoma.